Insmed Incorporated: Mizuho cuts target price to $154 from $195
INSM•Mizuho cut its target price for Insmed to $154 from $195.
Related News
Alnylam Pharmaceuticals Q3 revenue rises on AMVUTTRA demand
ALNY•
Midera Food Processing updates financial calendar
MFP•
Beyond Air schedules quarterly financial results conference call
XAIR•
Satellogic signs three-year non-Earth imaging agreement with HEO
SATL•
EU energy ministers discuss soaring fuel prices as winter looms
UNG•